Osteomyelitis: drug bioavailability and bone penetration are key.
Department of Infectious Diseases, Infection Control and Employee Health, University of Texas M.D. Anderson Cancer Center, Houston, USA.
Candice N
CN
White
Kenneth V I
KV
Rolston
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D001682:Biological Availability; D006801:Humans; D007263:Infusions, Parenteral; D010019:Osteomyelitis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism
D000900:Anti-Bacterial Agents